Institution
Nagoya City University
Also known as: Nagoya shiritsu daigaku · 名古屋市立大学
- 4running trials
- 32,929publications (OpenAlex)
Running trials
Recruiting
Recruiting
Ribociclib for HR-positive HER2-negative Metastatic Breast Cancer
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation1 recruiting
- Heart failure1 recruiting
- Metastatic breast cancer1 recruiting
- Sarcoidosis1 recruiting
Registry name variants (2)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Nagoya City University
Nagoya, 4678601
3 trials
NCT07164976Ribociclib for HR-positive HER2-negative Metastatic Breast Cancer
Contact: Kazuki Nozawa, MD
NCT03593759Cardiac Sarcoidosis Randomized Trial
Contact: K Nakasuka, MD
Nagoya City University Graduate School of Medical Sciences
Nagoya, Aichi-ken 467-8601
1 trial
Contact: Nobuyuki Ohte, MD, PhD
Conditions
Diseases this institution publishes on or runs trials for.
- Psoriasis23 works · 0 trials
- Metastatic breast cancer21 works · 2 trials
- Hydrocephalus9 works · 0 trials
- Cerebral palsy8 works · 0 trials
Institution data: ROR 04wn7wc95 (CC0-1.0)Updated 15 Nov 2026